These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21412203)

  • 1. Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humans.
    Kohli U; Hahn MK; English BA; Sofowora GG; Muszkat M; Li C; Blakely RD; Stein CM; Kurnik D
    Pharmacogenet Genomics; 2011 Apr; 21(4):171-8. PubMed ID: 21412203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Influencing the Cardiovascular Response to Subanesthetic Ketamine: A Randomized, Placebo-Controlled Trial.
    Liebe T; Li S; Lord A; Colic L; Krause AL; Batra A; Kretzschmar MA; Sweeney-Reed CM; Behnisch G; Schott BH; Walter M
    Int J Neuropsychopharmacol; 2017 Nov; 20(11):909-918. PubMed ID: 29099972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between major depressive disorder and the norepinephrine transporter polymorphisms T-182C and G1287A: a meta-analysis.
    Zhao X; Huang Y; Ma H; Jin Q; Wang Y; Zhu G
    J Affect Disord; 2013 Aug; 150(1):23-8. PubMed ID: 23648227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA.
    Vizeli P; Meyer Zu Schwabedissen HE; Liechti ME
    Eur J Clin Pharmacol; 2018 Mar; 74(3):275-283. PubMed ID: 29198060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norepinephrine transporter polymorphisms T-182C and G1287A are not associated with alcohol dependence and its clinical subgroups.
    Huang SY; Lu RB; Ma KH; Shy MJ; Lin WW
    Drug Alcohol Depend; 2008 Jan; 92(1-3):20-6. PubMed ID: 17630229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults.
    Marshe VS; Maciukiewicz M; Rej S; Tiwari AK; Sibille E; Blumberger DM; Karp JF; Lenze EJ; Reynolds CF; Kennedy JL; Mulsant BH; Müller DJ
    Am J Psychiatry; 2017 May; 174(5):468-475. PubMed ID: 28068779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between norepinephrine transporter gene polymorphism and alcohol dependence in Japanese].
    Narita S; Nagahori K; Nishizawa D; Yoshihara E; Kawai A; Murayama O; Ikeda K; Iwahashi K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2014 Dec; 49(6):330-9. PubMed ID: 25831948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polymorphism in the norepinephrine transporter gene is associated with affective and cardiovascular disease through a microRNA mechanism.
    Marques FZ; Eikelis N; Bayles RG; Lambert EA; Straznicky NE; Hering D; Esler MD; Head GA; Barton DA; Schlaich MP; Lambert GW
    Mol Psychiatry; 2017 Jan; 22(1):134-141. PubMed ID: 27046647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent association of polymorphisms in the promoter and 5'-untranslated region of the norepinephrine transporter gene with generalized anxiety disorder.
    Chang HA; Fang WH; Tzeng NS; Liu YP; Shyu JF; Wan FJ; Huang SY; Chang TC; Chang CC
    J Affect Disord; 2020 Jun; 270():124-130. PubMed ID: 32339102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between T-182C, G1287A polymorphism in NET gene and suicidality in major depressive disorder in Chinese patients.
    Cao SX; Li HF; Zhao XF; Pang JY; Liu Q; Xie GR
    Int J Psychiatry Clin Pract; 2018 Nov; 22(4):304-309. PubMed ID: 29703117
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET.
    Sigurdardottir HL; Kranz GS; Rami-Mark C; James GM; Vanicek T; Gryglewski G; Kautzky A; Hienert M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Rujescu D; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2016 Mar; 37(3):884-95. PubMed ID: 26678348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The T-182C Polymorphism Enhances Promoter Activity of the Norepinephrine Transporter Gene, but may not be Associated with Antidepressant Response.
    Zhao X; Cui W; Liu Q; Cao S; Pang J; Li H
    Genet Test Mol Biomarkers; 2020 Dec; 24(12):812-818. PubMed ID: 33290143
    [No Abstract]   [Full Text] [Related]  

  • 13. No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample.
    Renner TJ; Nguyen TT; Romanos M; Walitza S; Röser C; Reif A; Schäfer H; Warnke A; Gerlach M; Lesch KP
    Atten Defic Hyperact Disord; 2011 Sep; 3(3):285-9. PubMed ID: 21739117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between norepinephrine transporter T-182C polymorphism and major depressive disorder: a meta-analysis.
    Zhou Y; Su H; Song J; Guo L; Sun Y
    Neurosci Lett; 2014 Feb; 561():64-8. PubMed ID: 24374057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic depolarization stimulates norepinephrine transporter expression via catecholamines.
    Habecker BA; Willison BD; Shi X; Woodward WR
    J Neurochem; 2006 May; 97(4):1044-51. PubMed ID: 16573647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined effect of norepinephrine transporter gene and negative life events in major depression of Chinese Han population.
    Sun N; Xu Y; Wang Y; Duan H; Wang S; Ren Y; Peng J; Du Q; Shen Y; Xu Q; Zhang K
    J Neural Transm (Vienna); 2008 Dec; 115(12):1681-6. PubMed ID: 18779921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of catecholamines, age, and fitness on blood pressure reactivity to dynamic exercise in patients with essential hypertension.
    Braun LT; Potempa K; Holm K; Fogg L; Szidon JP
    Heart Lung; 1994; 23(5):404-12. PubMed ID: 7989209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymorphism in the noradrenaline transporter gene is associated with increased blood pressure in patients with resistant hypertension.
    Eikelis N; Marques FZ; Hering D; Marusic P; Head GA; Walton AS; Lambert EA; Esler MD; Sari CI; Schlaich MP; Lambert GW
    J Hypertens; 2018 Jul; 36(7):1571-1577. PubMed ID: 29677047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
    Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression.
    Kautto M; Kampman O; Mononen N; Lehtimäki T; Haraldsson S; Koivisto PA; Leinonen E
    Neurosci Lett; 2015 Mar; 590():116-20. PubMed ID: 25650523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.